We are thrilled to announce that Wellumix has raised $4,200,000 in Seed funding, led by Icehouse Ventures. This investment marks a pivotal moment in our journey to make personalized wellness accessible to everyone, and we are deeply grateful for the trust and vision that Icehouse Ventures has placed in our mission.

Why This Matters

The global wellness market is valued at over $4.5 trillion, yet the majority of people still lack access to truly personalized health guidance. Generic apps offer static advice that ignores individual biology, behavior patterns, and life circumstances. Traditional personalized wellness — nutritionists, personal trainers, wellness coaches — remains a luxury available only to the few.

Wellumix was created to close that gap. By combining AI with holistic health data, we deliver the kind of personalized guidance that was once reserved for elite athletes and executives — available to everyone at a fraction of the cost.

What We Have Built

Since launching publicly in early 2024, Wellumix has grown to 50,000 active users across 28 countries. Our platform integrates data from over 200 wearable devices and health apps to create a comprehensive, continuously updated picture of each user's wellness state. Key milestones to date:

About Icehouse Ventures

Icehouse Ventures is one of the most active early-stage investors in New Zealand and the broader Asia-Pacific region, with a portfolio spanning health technology, SaaS, and consumer platforms. Their track record of backing mission-driven founders with global ambitions made them the ideal partner for this stage of our journey.

"Wellumix is addressing one of the most significant opportunities in consumer health technology," said a spokesperson for Icehouse Ventures. "The combination of a deeply experienced founding team, a compelling product that drives measurable outcomes, and a large underserved market positions Wellumix for exceptional growth. We are excited to partner with them on this journey."

How We Will Use the Funding

The $4.2M Seed round will be deployed across three primary areas over the next 18 months:

AI and Machine Learning Development (40%)

We are expanding our AI team to accelerate the development of our personalization engine. Planned improvements include more sophisticated behavioral modeling, improved prediction of health interventions that will resonate with specific user profiles, and a new natural language interface that allows users to interact with their health data conversationally.

Clinical Research and Validation (25%)

Rigorous scientific validation is at the core of our value proposition. We are partnering with three additional academic medical centers to conduct randomized controlled trials demonstrating the efficacy of our platform for specific health outcomes including stress reduction, sleep quality improvement, and metabolic health management.

Team Growth and Infrastructure (35%)

We are growing from 18 to 35 team members across engineering, clinical science, product, and customer success. We are also investing in enterprise-grade infrastructure to support our expanding user base and new corporate wellness partnerships.

The Road Ahead

This funding is not just a milestone — it is a mandate. More than 50,000 people trust Wellumix with their most personal data and their most important goals. The responsibility that comes with that trust drives every decision we make.

In the months ahead, you can expect Wellumix to deepen its AI capabilities, expand integrations with leading healthcare providers, and launch new programs targeting specific wellness challenges including corporate burnout, postpartum wellness, and chronic disease management.

We are just getting started. Thank you to our users, our team, and our investors for making this possible. The best is yet to come.

— Shieak Tzeng, CEO, Wellumix